Abstract
Historically, premature ejaculation (PE) was considered to be an acquired psychosexual phenomenon. Hence, behavioral therapies such as “stop-start” and “squeeze” methods were popular management approaches albeit with limited success. Observation of delayed ejaculation in patients taking selective serotoninergic reuptake inhibitors (SSRI) has contributed to the serendipitous advent of pharmacotherapy using SSRI for PE. Serotonin on the whole exerts an inhibitory effect on ejaculation both at the spinal and supraspinal levels. Many serotonin receptor subtypes have been identified so far, each having different functions. Other neurotransmitters implicated to play a secondary role in ejaculatory process include dopamine, acetylcholine, adrenaline, neuropeptides, oxytocin, gamma aminobutyric acid, and nitric oxide.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for “on demand” treatment of premature ejaculation. BJU Int. 2006;97:311–5.
Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999;11(5):261–4.
Dinsmore WW, Wyllie MG. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo controlled study. BJU Int. 2009;103:940–9.
Dinsmore WW, Hackett G, Goldmeier D, et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int. 2006;99:369–75.
Gurkan L, Oommen M, Hellstrom WJG. Premature ejaculation: current and future treatments. Asian J Androl. 2008;10(1):102–9.
Hellstrom WJG. Emerging treatments for premature ejaculation: focus on dapoxetine. Neuropsychiatr Dis Treat. 2009;5:37–46.
Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int. 2008;80(2):162–5.
McMahon CG. Long-term results of treatment of premature ejaculation with selective serotonin re-uptake inhibitors. Int J Impot Res. 2002;14:S19.
Modi NB, Dresser MJ, Simon M, Lin D, Desai D, Gupta S. Single and multiple dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol. 2006;46(3):301–9.
Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomized-controlled trials. Lancet. 2006;368(9539):929–37.
Sadeghi-Nejad H, Watson W. Premature ejaculation: current medical treatment and new directions. J Sex Med. 2008;5:1037–50.
Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA. Tramadol HCl has promise in an on-demand use to treat premature ejaculation. J Sex Med. 2008;5(1):188–93.
Salonia A, Maga T, Colombo R, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol. 2002;168(6):2486–9.
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004a;16:369–81.
Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stop-watch assessment. Eur Urol. 2004b;46:510–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Adaikan, P.G., Srilatha, B. (2013). Choice of Pharmacologic Agents. In: Lim, P. (eds) Men's Health. Springer, London. https://doi.org/10.1007/978-1-4471-4766-4_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4766-4_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4765-7
Online ISBN: 978-1-4471-4766-4
eBook Packages: MedicineMedicine (R0)